Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Campus
Campus

Cardiovascular Diseases

Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.

Science in Cardiovascular Diseases

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)
  • Dyslipidemia

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Learn More
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
  • Dyslipidemia

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Learn More
Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia
  • Dyslipidemia

Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia

Learn More
Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry
  • Dyslipidemia

Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry

Learn More
Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study
  • Dyslipidemia

Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study

Learn More
PCSK9 inhibitors and ACS
  • Dyslipidemia

PCSK9 inhibitors and ACS

Learn More
Evaluation of lipid management following ACS
  • Dyslipidemia

Evaluation of lipid management following ACS

Learn More
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry
  • Dyslipidemia

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the SAFEHEART registry

Learn More

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab
  • Cardiovascular
  • Dyslipidemia

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Learn More
Benefit of Prophylaxis for High-Risk Surgical Patients
  • Cardiovascular

Benefit of Prophylaxis for High-Risk Surgical Patients

Learn More
Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery
  • Thrombosis
  • Cardiovascular

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Learn More
VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients
  • Thrombosis
  • Cardiovascular

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Learn More
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress
  • Cardiovascular
  • Dyslipidemia

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Learn More

Events

Stay up to date and register for the latest events and view webinar recordings

VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

VTE Safety Zone: Prof. Juan Arcelus - Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Learn More
World Hypertension Day Ep. 2

World Hypertension Day Ep. 2

Learn More
World Hypertension Day Ep. 1

World Hypertension Day Ep. 1

Learn More
Challenges of VTE Prophylaxis in Surgery

Challenges of VTE Prophylaxis in Surgery

Learn More
Venous Thromboembolism in Acutely Medically Ill Patients

Venous Thromboembolism in Acutely Medically Ill Patients

Learn More
Venous Thromboembolism Burden

Venous Thromboembolism Burden

Learn More
VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

Learn More
VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

Learn More